Stephen M. Ansell, MD, PhD, on Hematologic Malignancies: Immunotherapy Update

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Stephen M. Ansell, MD, PhD, of the Mayo Clinic, discusses integrating immune checkpoint inhibitors, improving efficacy, and reducing toxicity when treating blood cancers.

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.